Education
About Us
Working with TipRanks
Follow Us
Quoin Pharmaceuticals (QNRX)
NASDAQ:QNRX
Qrx003, 4% Lotion
Netherton Syndrome
Phase II/III
Recruiting
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Apr 07, 2025
―
Qrx003, 4% Lotion
Netherton Syndrome
Phase II/III
Recruiting
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Mar 16, 2023
―
Vehicle, Qrx003-2% Lotion, Qrx003-4% Lotion Qam, Qrx003-4% Lotion Bid
Netherton Syndrome
Phase II/III
Recruiting
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
Aug 17, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Quoin Pharmaceuticals (QNRX) have in its pipeline
QNRX is currently developing the following drugs: Qrx003, 4% Lotion, Qrx003, 4% Lotion, Vehicle, Qrx003-2% Lotion, Qrx003-4% Lotion Qam, Qrx003-4% Lotion Bid. These drug candidates are in various stages of clinical development as the company works toward FDA approval.